Betty K. Samulitis

491 total citations
15 papers, 396 citations indexed

About

Betty K. Samulitis is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Betty K. Samulitis has authored 15 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Betty K. Samulitis's work include Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (3 papers) and Click Chemistry and Applications (2 papers). Betty K. Samulitis is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (3 papers) and Click Chemistry and Applications (2 papers). Betty K. Samulitis collaborates with scholars based in United States and Czechia. Betty K. Samulitis's co-authors include Robert T. Dorr, Terry H. Landowski, Garth Powis, Alfred Gallegos, Amanda F. Baker, Bryan Husbeck, Margareta Berggren, H.‐H. Sherry Chow, Lee Wisner and Margaret M. Briehl and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

Betty K. Samulitis

15 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Betty K. Samulitis United States 11 249 100 76 66 26 15 396
Koc-Kan Ho United States 12 328 1.3× 64 0.6× 73 1.0× 82 1.2× 31 1.2× 17 476
Laura Caboni Ireland 9 289 1.2× 76 0.8× 74 1.0× 81 1.2× 18 0.7× 11 441
Dominique Kreutz Austria 12 201 0.8× 64 0.6× 113 1.5× 43 0.7× 58 2.2× 15 390
Sachio Shibata Japan 10 229 0.9× 54 0.5× 41 0.5× 35 0.5× 15 0.6× 14 312
Pierre Champelovier France 12 165 0.7× 102 1.0× 65 0.9× 40 0.6× 34 1.3× 17 354
Kun Yao China 10 242 1.0× 49 0.5× 51 0.7× 91 1.4× 13 0.5× 20 361
David K. Miyamoto United States 8 320 1.3× 110 1.1× 85 1.1× 42 0.6× 26 1.0× 9 406
Rhushikesh A. Kulkarni United States 11 287 1.2× 113 1.1× 75 1.0× 53 0.8× 62 2.4× 16 442
Kamlesh Yadav India 11 460 1.8× 58 0.6× 93 1.2× 67 1.0× 32 1.2× 24 568
José D. Solano Mexico 13 233 0.9× 159 1.6× 59 0.8× 47 0.7× 14 0.5× 22 450

Countries citing papers authored by Betty K. Samulitis

Since Specialization
Citations

This map shows the geographic impact of Betty K. Samulitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty K. Samulitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty K. Samulitis more than expected).

Fields of papers citing papers by Betty K. Samulitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty K. Samulitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty K. Samulitis. The network helps show where Betty K. Samulitis may publish in the future.

Co-authorship network of co-authors of Betty K. Samulitis

This figure shows the co-authorship network connecting the top 25 collaborators of Betty K. Samulitis. A scholar is included among the top collaborators of Betty K. Samulitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty K. Samulitis. Betty K. Samulitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Samulitis, Betty K., Anne E. Cress, Hitendra Patel, et al.. (2014). Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biology & Therapy. 16(1). 43–51. 54 indexed citations
2.
Landowski, Terry H., Betty K. Samulitis, & Robert T. Dorr. (2013). The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers. Investigational New Drugs. 31(6). 1616–1625. 15 indexed citations
3.
Tome, Margaret E., Jennifer B. Frye, Donna L. Coyle, et al.. (2012). Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance. Experimental and Therapeutic Medicine. 3(5). 845–852. 26 indexed citations
4.
Шевелева, Елена, Terry H. Landowski, Betty K. Samulitis, et al.. (2012). Imexon Induces an Oxidative Endoplasmic Reticulum Stress Response in Pancreatic Cancer Cells. Molecular Cancer Research. 10(3). 392–400. 22 indexed citations
5.
Dorr, Robert T., Lee Wisner, Betty K. Samulitis, Terry H. Landowski, & William A. Remers. (2011). Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423. Cancer Chemotherapy and Pharmacology. 69(4). 1039–1049. 10 indexed citations
6.
Samulitis, Betty K., Robert T. Dorr, & H.‐H. Sherry Chow. (2011). Interaction of dacarbazine and imexon, in vitro and in vivo, in human A375 melanoma cells.. PubMed. 31(9). 2781–5. 7 indexed citations
7.
Samulitis, Betty K., et al.. (2010). Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase. Cancer Chemotherapy and Pharmacology. 67(1). 183–192. 6 indexed citations
8.
Shaw, Arthur Y., Meredith C. Henderson, Gary A. Flynn, et al.. (2009). Characterization of Novel Diaryl Oxazole-Based Compounds as Potential Agents to Treat Pancreatic Cancer. Journal of Pharmacology and Experimental Therapeutics. 331(2). 636–647. 47 indexed citations
9.
Samulitis, Betty K., Terry H. Landowski, & Robert T. Dorr. (2008). Inhibition of protein synthesis by imexon reduces HIF-1α expression in normoxic and hypoxic pancreatic cancer cells. Investigational New Drugs. 27(1). 89–98. 10 indexed citations
10.
Scott, Julie A., Robert T. Dorr, Betty K. Samulitis, & Terry H. Landowski. (2007). Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines. Cancer Chemotherapy and Pharmacology. 59(6). 749–757. 15 indexed citations
11.
Dragovich, Tomislav, Michael S. Gordon, David S. Mendelson, et al.. (2007). Phase I Trial of Imexon in Patients With Advanced Malignancy. Journal of Clinical Oncology. 25(13). 1779–1784. 40 indexed citations
12.
Pourpak, Alan, Ross O. Meyers, Betty K. Samulitis, et al.. (2006). Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice. Anti-Cancer Drugs. 17(10). 1179–1184. 11 indexed citations
13.
Tome, Margaret E., David B. Johnson, Betty K. Samulitis, Robert T. Dorr, & Margaret M. Briehl. (2006). Glucose 6-Phosphate Dehydrogenase Overexpression Models Glucose Deprivation and Sensitizes Lymphoma Cells to Apoptosis. Antioxidants and Redox Signaling. 8(7-8). 1315–1327. 21 indexed citations
14.
Samulitis, Betty K., Terry H. Landowski, & Robert T. Dorr. (2005). Correlates of imexon sensitivity in human multiple myeloma cell lines. Leukemia & lymphoma. 47(1). 97–109. 12 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koc-Kan Ho Breakdown of academic impact, for papers by Laura Caboni Breakdown of academic impact, for papers by Dominique Kreutz Breakdown of academic impact, for papers by Sachio Shibata Breakdown of academic impact, for papers by Pierre Champelovier Breakdown of academic impact, for papers by Kun Yao Breakdown of academic impact, for papers by David K. Miyamoto Breakdown of academic impact, for papers by Rhushikesh A. Kulkarni Breakdown of academic impact, for papers by Kamlesh Yadav Breakdown of academic impact, for papers by José D. Solano
Rankless by CCL
2026